Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025 - PubMed
4 hours ago
- #Asia-Pacific
- #health policy
- #prostate cancer
- The Asia-Pacific Advanced Prostate Cancer Symposium 2025 discussed the application of outcomes from the APCCC 2024 in the Asia-Pacific region.
- The symposium covered five key topics: high-risk localized/locally advanced prostate cancer, PSA persistence and recurrence, radioligand therapy, genetics and genomics, and bone protection/supportive care.
- Challenges in the region include variations in access and reimbursement for treatments like PSMA-PET/CT, abiraterone, and 177Lu-PSMA, as well as limited access to genetic counsellors.
- Creative approaches were highlighted to minimize costs while maximizing patient options.
- The symposium emphasized the importance of multidisciplinary and personalized management, along with the need for locally relevant data to inform APAC-specific guidelines.